Automated commercial environment

Ended Awarded Last action

Contract number
75F40122F80151
Awardee
Awarding agency
Obligated
$11,945,424

Award facts

Contract value 100% obligated
$11,945,424.02 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
8(a) Sole Source
Competition
Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Herndon, VA 20170, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00004 · Automated commercial environment option year 4 $1,692,309
Exercise an Option P00003 · Automated commercial environment option year 3 $1,676,432
Exercise an Option P00002 $2,548,915
Exercise an Option P00001 $2,625,544
Original award $3,402,225

About this award

The Food and Drug Administration awarded a $11.9M delivery order to Tuvli LLC on May 12, 2022, under the 8(a) STARS III Governmentwide Acquisition Contract with an ultimate completion date of May 26, 2026. This award represents Option Year 4 of the Automated Commercial Environment program and carries an 8(a) sole source set-aside designation. Tuvli LLC, an Alaskan Native Corporation-owned and minority-owned small disadvantaged business headquartered in Herndon, Virginia, was selected to continue providing specialized services under this established contract vehicle. The work will be performed in Herndon, Virginia, and the contract utilizes firm fixed price pricing.

Tuvli LLC brings substantial expertise in providing professional services and information technology solutions to federal civilian agencies. The company holds significant federal contract vehicles including a $95M FDA Oracle database administration support contract and access to the $50B STARS III GWAC, through which it has demonstrated capability in database administration, infrastructure support, and IT modernization services. The 8(a) STARS III vehicle enables small disadvantaged businesses like Tuvli to pursue both sole-source and competitive task orders across federal civilian and defense agencies, supporting the government's commitment to contracting opportunities for certified small businesses while meeting critical agency operational and technology needs.

Quick answers

Who was awarded contract 75F40122F80151?

75F40122F80151 was awarded to Tuvli LLC by Food and Drug Administration (Department of Health and Human Services) on May 12, 2022.

How much is contract 75F40122F80151 worth?

The government has obligated $11,945,424 on 75F40122F80151.

Is contract 75F40122F80151 an order under another contract?

Yes. 75F40122F80151 is a delivery order under 47QTCB21D0359, a government wide acquisition contract (GWAC), on 8(a) STARS III (STARS III).

Was contract 75F40122F80151 competed?

The extent of competition for 75F40122F80151 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: 8(a) Sole Source.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award